Pharma Logistics Market has Evolved Significantly After the Outbreak of the COVID-19 Pandemic, with Vaccine Distributions Getting Streamlined. The Market is Set to Reach USD 146.71 Billion By 2027 - Arizton

CHICAGO, Jan. 11, 2023 /PRNewswire/ -- According to Arizton's latest research report, the pharmaceutical logistics market is expected to grow at a CAGR of 8% during 2021-2027. Increased usage of logistics optimization tools, AI, IoT, and intelligent logistics platforms are likely to contribute to the future growth of the pharmaceutical logistics market. North America region accounts for the highest revenue share of 38.70% in the global pharmaceutical logistics market in 2021 and holds the presence of most pharmaceutical suppliers. The US is the leading country worldwide with the highest share of pharmaceuticals. About five top pharmaceutical companies in 2020 were from the US. In the US, branded drugs accounted for around 83.9% of spending. In 2020, about 8.1% of worldwide drug and medicine shipments originated from North America.

Cold chain logistics companies have made a huge footprint since the onset of COVID-19 pandemic due to the growing demand for temperature-controlled biologics, especially vaccines. Since the beginning of 2020, the adoption of state-of-the-art technologies such as telematics and remote monitoring in cold chain logistics is making transportation in the pharmaceutical industry more efficient with better safety and connectivity. 

On an average, a drug manufacturer can expect a damage rate of around 30% owing to the logistics constraints associated with a pharmaceutical product. In fact, around 25% of vaccines that reach their destination deteriorate due to incorrect shipping, while around 20% of temperature-sensitive drugs experience broken cold chains. As a result, pharma & biotech companies are utilizing logistics from expert logistic providers who can seamlessly deliver drugs across the supply chain, thereby contributing to the overall growth of the market. 

Third-party logistics companies are utilizing cloud computing solutions and installing IoT devices in refrigerated trucks and containers to facilitate real-time remote temperature monitoring during the transportation of temperature-sensitive drugs and vaccines.

Pharmaceutical Logistics Market Report Scope

Click Here to Download the Free Sample Report

Digital transformation is expected to offer an opportunity for pharmaceutical logistics companies to gain a competitive advantage. Digitalization can be extremely beneficial to both small and large firms in the pharmaceutical industry. For example, digitalization to develop counterfeit-proof pharmaceuticals with trackable serial numbers to ensure quality while satisfying forthcoming serialization regulations. Pharmaceutical firms can also embrace digitization to fulfill the predicted rise in demand from global markets. They may use digitalization to comply with regulations, uncover manufacturing efficiencies to reduce costs, and swiftly interact with suppliers and distributors using cloud-based information exchanges.

DB Schenker, a subsidiary of DB Group, a leading provider in the logistics sector, uses technologies and methods of digitalization to offer customers an attractive range of products. On the one hand, it is incorporating new transport offers into its product portfolio, such as on-demand mobility, and establishing new platforms for its customer interfaces. On the other hand, it supports internal processes with technologies, such as AI, so the company can continue to offer customers fair prices with efficient processes. According to the company, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential to increase transport density and reliability.

In 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group (provides priority logistics and transportation solutions for time and temperature-sensitive life science and healthcare products) to provide industry-leading digital supply chain IT solutions for cell and gene therapies. TrakCel is the first provider of integrated cellular orchestration solutions for tracking cell and gene therapy products. Its goal is to provide cell and gene therapy software solutions.

Why Should You Buy this Research Report?

• In-depth data and analysis of the global pharmaceutical logistics market's growth over the ensuing six years.
• Global pharmaceutical logistics extensions market size estimation and contribution in the market.
• Predictions on upcoming trends and changes in consumer behavior.
• Analysis of the market's competitive environment and exhaustive vendor information.
• Detailed information on the variables posing challenges to vendors in the global pharmaceutical logistics market.

The report considers the present scenario of the pharmaceutical logistics market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market. Click Here to Download the Free Sample Report

Key Leading Vendors

• AmerisourceBergen
• CEVA Logistics
• DB Group
• Deutsche Post DHL
• FedEx
• Kuehne + Nagel
• United Parcel Service
• ABS Logistics
• AWL India
• Alloga
• BOLLORÉ LOGISTICS
• Cardinal Health
• C.H. Robinson
• Cold Chain Technologies
• CRYOPDP
• DPD
• DSV
• Farmasoft
• Jeena & Company
• Lufthansa Cargo
• Maersk
• Medline
• Nippon Express
• Noatum Logistics
• Owens & Minor
• Oximio
• Pharma Logistics
• PHOENIX Group
• Parexel International
• SEKO Logistics
• Singapore Post
• SINOTRANS
• XPO Logistics
• Yourway
• YUSEN LOGISTICS

Market Segmentation

Therapy Area

• Communicable Diseases
• Oncology
• Diabetes
• Cardiovascular Diseases
• Autoimmune Diseases
• Neurological Disorders
• Pain Management
• Respiratory Diseases
• Others

Origin

• Branded
• Generic
• OTC

Product

• Small Molecule Drugs
• Biologics

Function

• Transportation
• Warehousing
• Others

Geography

• North America
• US
• Canada
• Europe
• Germany
• Italy
• Spain
• France
• UK
• APAC
• Japan
• China
• South Korea
• India
• Australia
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• South Africa

Check Out Some of the Top-Selling Related Research Report

Pharmaceutical Packaging Market - The global pharmaceutical packaging market is expected to grow at a CAGR of 4.65% and will cross USD 106.37 billion by 2027 from USD 81 billion in 2021 from 2021-2027. The demand for advanced and innovative solutions, such as self-administered drug delivery devices, is rising in high-income countries, bringing lucrative opportunities for the pharmaceutical packaging market. 

Biopharmaceutical Excipients Market - The global biopharmaceutical excipients market is expected to reach $3.2 billion by 2027. Excipients are fundamental components of any biopharmaceutical drug product, which act as active ingredients, stability enhancers, emulsifying and suspending agents, binders, preservatives, antioxidants, and lubricants. These differ from prodrugs in manufacturing or are present in a finished pharmaceutical product dosage form. Excipients have targeted roles, ranging from protecting the API to easing the manufacturing process, which, in turn, drives the need and stipulation of excipients for developing effective formulations.

Medical Device Packaging Market -  The global medical device packaging market is expected to grow at a CAGR of over 5.5% from 2022 to 2027. Medical device packaging involves the sterilization of surgical equipment and medical imaging devices. It is performed to keep medical devices free from any contamination. Medical device packaging provides a protective layer, thereby reducing infections.

Healthcare Logistics Market –  The global healthcare logistics market is expected to reach USD 226.57 billion by 2026. The main factors contributing to the growth of the global healthcare logistics industry are the increasing demand for pharmaceuticals and medical devices, emerging technologies in the healthcare supply chain, a growing collaboration between logistics and healthcare providers, and other factors such as a rising population and growing chronic disease cases increasing trade, etc. Due to the emerging demand for vaccines, COVID-19 was a catalyst for the global healthcare logistics market.

Table of Content

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY THERAPY AREA

4.3.2 MARKET SEGMENTATION BY ORIGIN

4.3.3 MARKET SEGMENTATION BY PRODUCT

4.3.4 MARKET SEGMENTATION BY FUNCTION

4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 BACKGROUND

7.2 IMPACT OF COVID-19 ON THE GLOBAL SUPPLY CHAIN

8 PREMIUM INSIGHTS

9 MARKET OPPORTUNITIES & TRENDS

9.1 GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS

9.2 DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS

9.3 INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS

10 MARKET GROWTH ENABLERS

10.1 INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES

10.2 GROWING DEMAND FOR OCEAN FREIGHT SERVICE

10.3 INCREASING DEMAND FOR GENERICS AND BIOSIMILARS

11 MARKET RESTRAINTS

11.1 LACK OF COMPLIANCE AND CHANGING REGULATIONS

11.2 IMPACT OF THE COVID-19 PANDEMIC

11.3 GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHTS BY THERAPY AREA

12.2.2 INSIGHTS BY ORIGIN

12.2.3 INSIGHTS BY PRODUCT

12.2.4 INSIGHTS BY FUNCTION

12.2.5 INSIGHTS BY GEOGRAPHY

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

13 THERAPY AREA

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 COMMUNICABLE DISEASES

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 ONCOLOGY

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 DIABETES

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

13.6 CARDIOVASCULAR DISEASES

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.6.3 MARKET BY GEOGRAPHY

13.7 AUTOIMMUNE DISEASES

13.7.1 MARKET OVERVIEW

13.7.2 MARKET SIZE & FORECAST

13.7.3 MARKET BY GEOGRAPHY

13.8 NEUROLOGICAL DISORDERS

13.8.1 MARKET OVERVIEW

13.8.2 MARKET SIZE & FORECAST

13.8.3 MARKET BY GEOGRAPHY

13.9 PAIN MANAGEMENT

13.9.1 MARKET OVERVIEW

13.9.2 MARKET SIZE & FORECAST

13.9.3 MARKET BY GEOGRAPHY

13.10 RESPIRATORY DISEASES

13.10.1 MARKET OVERVIEW

13.10.2 MARKET SIZE & FORECAST

13.10.3 MARKET BY GEOGRAPHY

13.11 OTHERS

13.11.1 MARKET OVERVIEW

13.11.2 MARKET SIZE & FORECAST

13.11.3 MARKET BY GEOGRAPHY

14 ORIGIN

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 BRANDED DRUGS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 GENERIC DRUGS

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 OTC

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

15 PRODUCT

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 SMALL MOLECULE DRUGS

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 BIOLOGICS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

15.5 MONOCLONAL ANTIBODIES

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.6 VACCINES

15.6.1 MARKET OVERVIEW

15.6.2 MARKET SIZE & FORECAST

15.7 OTHERS

15.7.1 MARKET OVERVIEW

15.7.2 MARKET SIZE & FORECAST

16 FUNCTION

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 TRANSPORTATION

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.3.3 MARKET BY GEOGRAPHY

16.4 ROAD

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.5 WATER

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.6 AIR

16.6.1 MARKET OVERVIEW

16.6.2 MARKET SIZE & FORECAST

16.7 WAREHOUSING

16.7.1 MARKET OVERVIEW

16.7.2 MARKET SIZE & FORECAST

16.7.3 MARKET BY GEOGRAPHY

16.8 OTHERS

16.8.1 MARKET OVERVIEW

16.8.2 MARKET SIZE & FORECAST

16.8.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 NORTH AMERICA BY THERAPY AREA

18.4 NORTH AMERICA BY ORIGIN

18.5 NORTH AMERICA BY PRODUCT

18.6 NORTH AMERICA BY FUNCTION

18.7 KEY COUNTRIES

18.7.1 US: MARKET SIZE & FORECAST

18.7.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 EUROPE BY THERAPY AREA

19.4 EUROPE BY ORIGIN

19.5 EUROPE BY PRODUCT

19.6 EUROPE BY FUNCTION

19.7 KEY COUNTRIES

19.7.1 GERMANY: MARKET SIZE & FORECAST

19.7.2 FRANCE: MARKET SIZE & FORECAST

19.7.3 UK: MARKET SIZE & FORECAST

19.7.4 ITALY: MARKET SIZE & FORECAST

19.7.5 SPAIN: MARKET SIZE & FORECAST

20 APAC

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 APAC BY THERAPY AREA

20.4 APAC BY ORIGIN

20.5 APAC BY PRODUCT

20.6 APAC BY FUNCTION

20.7 KEY COUNTRIES

20.7.1 CHINA: MARKET SIZE & FORECAST

20.7.2 JAPAN: MARKET SIZE & FORECAST

20.7.3 INDIA: MARKET SIZE & FORECAST

20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST

20.7.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 LATIN AMERICA BY THERAPY AREA

21.4 LATIN AMERICA BY ORIGIN

21.5 LATIN AMERICA BY PRODUCT

21.6 LATIN AMERICA BY FUNCTION

21.7 KEY COUNTRIES

21.7.1 BRAZIL: MARKET SIZE & FORECAST

21.7.2 MEXICO: MARKET SIZE & FORECAST

21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

22.1 MARKET OVERVIEW

22.2 MARKET SIZE & FORECAST

22.3 MIDDLE EAST & AFRICA BY THERAPY AREA

22.4 MIDDLE EAST & AFRICA BY ORIGIN

22.5 MIDDLE EAST & AFRICA BY PRODUCT

22.6 MIDDLE EAST & AFRICA BY FUNCTION

22.7 KEY COUNTRIES

22.7.1 TURKEY: MARKET SIZE & FORECAST

22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST

22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

23.1 COMPETITION OVERVIEW

23.1.1 AMERISOURCEBERGEN

23.1.2 DB GROUP

23.1.3 DEUTSCHE POST DHL

23.1.4 CEVA LOGISTICS

23.1.5 UNITED PARCEL SERVICE

23.1.6 FEDEX

23.1.7 KUEHNE+NAGEL

24 KEY COMPANY PROFILES

24.1 AMERISOURCEBERGEN

24.1.1 BUSINESS OVERVIEW

24.1.2 SERVICE OFFERINGS

24.1.3 KEY STRATEGIES

24.1.4 KEY STRENGTHS

24.1.5 KEY OPPORTUNITIES

24.2 CEVA LOGISTICS

24.3 DB GROUP

24.4 DEUTSCHE POST DHL

24.5 FEDEX

24.6 KUEHNE + NAGEL

24.7 UNITED PARCEL SERVICE

25 OTHER PROMINENT VENDORS

25.1 ABS LOGISTICS

25.1.1 BUSINESS OVERVIEW

25.1.2 SERVICE OFFERINGS

25.2 AWL INDIA

25.3 ALLOGA

25.4 BOLLORÉ LOGISTICS

25.5 CARDINAL HEALTH

25.6 C.H. ROBINSON

25.7 COLD CHAIN TECHNOLOGIES

25.8 CRYOPDP

25.9 DPD

25.10 DSV

25.11 FARMASOFT

25.12 JEENA & COMPANY

25.13 LUFTHANSA CARGO

25.14 A.P. MOLLER - MAERSK

25.15 MEDLINE

25.16 NIPPON EXPRESS

25.17 NOATUM LOGISTICS

25.18 OWENS & MINOR

25.19 OXIMIO

25.20 PHARMA LOGISTICS

25.21 PHOENIX GROUP

25.22 PAREXEL INTERNATIONAL

25.23 SEKO LOGISTICS

25.24 SINGAPORE POST

25.25 SINOTRANS

25.26 XPO LOGISTICS

25.27 YOURWAY

25.28 YUSEN LOGISTICS

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS

26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

27.1 MARKET BY GEOGRAPHY

27.2 MARKET BY THERAPY AREA

27.3 MARKET BY ORIGIN

27.4 MARKET BY PRODUCT

27.5 MARKET BY FUNCTION

27.6 NORTH AMERICA BY THERAPY AREA

27.7 NORTH AMERICA BY ORIGIN

27.8 NORTH AMERICA BY PRODUCT

27.9 NORTH AMERICA BY FUNCTION

27.10 EUROPE BY THERAPY AREA

27.11 EUROPE BY ORIGIN

27.12 EUROPE BY PRODUCT

27.13 EUROPE BY FUNCTION

27.14 APAC BY THERAPY AREA

27.15 APAC BY ORIGIN

27.16 APAC BY PRODUCT

27.17 APAC BY FUNCTION

27.18 LATIN AMERICA BY THERAPY AREA

27.19 LATIN AMERICA BY ORIGIN

27.20 LATIN AMERICA BY PRODUCT

27.21 LATIN AMERICA BY FUNCTION

27.22 MIDDLE EAST & AFRICA AMERICA BY THERAPY AREA

27.23 MIDDLE EAST & AFRICA BY ORIGIN

27.24 MIDDLE EAST & AFRICA BY PRODUCT

27.25 MIDDLE EAST & AFRICA BY FUNCTION

28 APPENDIX

28.1 ABBREVIATIONS

About Us:

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.  

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.  

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.  

Click Here to Contact Us  

Call: +1-312-235-2040  

          +1 302 469 0707  

Mail: enquiry@arizton.com

Photo: https://mma.prnewswire.com/media/1981618/Pharmaceutical_Logistics_Market.jpg
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg